MIRA Pharmaceuticals Inc. (MIRA)
NASDAQ: MIRA
· Real-Time Price · USD
1.51
0.04 (2.72%)
At close: Aug 15, 2025, 3:59 PM
1.48
-1.97%
After-hours: Aug 15, 2025, 07:51 PM EDT
MIRA Pharmaceuticals Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Mar 31, 2021 |
PE Ratio | -2.29 | -1.83 | -2.4 | -1.44 | -3.1 | -0.67 | -4.79 | -18.74 | -17.65 | -17.54 | -13.07 | -9.77 | -16.04 | -415.38 |
PEG Ratio | 0.07 | -0.13 | -0.09 | -0.06 | 0.04 | -0.01 | -0.03 | 3.28 | 26.91 | 0.74 | 0.52 | -0.16 | n/a | n/a |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 12.60 | 8.00 | 5.48 | 4.39 | 6.74 | 3.55 | 8.47 | 79.30 | -52.9 | -158.77 | n/a | n/a | 37.79 | -1.39K |
P/FCF Ratio | -10.01 | -9.75 | -10.64 | -11.27 | -20.28 | -7.27 | -39.02 | -143.6 | -88.03 | -97.05 | -71.99 | -74.43 | -46.35 | -5.76K |
P/OCF Ratio | -10.01 | -9.75 | -10.64 | -11.27 | -20.28 | -7.27 | -39.02 | -143.6 | -88.03 | -97.05 | -71.99 | -74.43 | -46.35 | -5.76K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.00 | 0.01 | 1.61 | -0.2 | -0.82 | n/a | n/a | 0.17 | n/a |
Quick Ratio | 12.86 | 3.99 | 6.11 | 3.68 | 5.70 | 8.70 | 6.99 | 0.16 | 0.12 | 0.36 | n/a | n/a | 3.97 | n/a |
Current Ratio | 12.86 | 3.99 | 6.11 | 3.68 | 5.70 | 8.70 | 6.99 | 0.16 | 0.12 | 0.36 | n/a | n/a | 3.97 | n/a |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | -1.12 | -7.39 | -3.28 | -810.28 | -763.14 | -783.87 | -1.05K | -380.94 | n/a |
Return on Equity | -1.38 | -1.09 | -0.57 | -0.76 | -0.54 | -1.32 | -0.44 | -1.06 | 0.75 | 2.26 | n/a | n/a | -0.59 | 0.84 |
Return on Assets | -1.27 | -0.82 | -0.48 | -0.56 | -0.45 | -1.17 | -0.4 | -0.33 | -3.37 | -1.57 | n/a | n/a | -0.46 | n/a |
Return on Invested Capital | -1.39 | -1.11 | -0.58 | -0.78 | -0.56 | -0.7 | -0.38 | -0.31 | 0.94 | 12.82 | n/a | n/a | -0.5 | n/a |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |